Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | KDM6B | O15054 | 1/20 | 0.38 |
| ▸ | KDM5C | P41229 | 1/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.38 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.38 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.37 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetoacetic Acid SCHEMBL2381598 | 1.00 | HDAC1 (0.41) | HDAC1HDAC2TDP1CHRM1AKR1A1 | |
| Acetoacetic Acid SCHEMBL867995 | 0.89 | ALOX15 (0.41) | HDAC1HDAC2TDP1CHRM1AKR1A1 | |
| Malonic Acid SCHEMBL28697215 | 0.88 | LDHA (0.47) | HDAC1HDAC2TDP1CHRM1AKR1A1 | |
| Acetoacetic Acid SCHEMBL9681644 | 0.87 | GPR84 (0.42) | GPR84FFAR1FFAR4TSHRALDH1A1 | |
| Acetoacetic Acid SCHEMBL9680475 | 0.87 | GPR84 (0.42) | GPR84FFAR1FFAR4TSHRALDH1A1 | |
| Acetoacetic Acid SCHEMBL1627295 | 0.85 | GPR84 (0.50) | TDP1GPR84FFAR1FFAR4TSHR | |
| Acetoacetic Acid SCHEMBL3909150 | 0.83 | KDM4E (0.42) | HDAC1HDAC2TDP1KDM4EKDM6B | |
| Acetoacetic Acid SCHEMBL3627073 | 0.83 | KDM4E (0.42) | HDAC1HDAC2TDP1KDM4EKDM6B | |
| Acetic Acid SCHEMBL11353075 | 0.83 | CHRM1 (0.50) | HDAC1HDAC2TDP1CHRM1AKR1A1 | |
| Acetic Acid SCHEMBL11353114 | 0.83 | CHRM1 (0.50) | HDAC1HDAC2TDP1CHRM1AKR1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230285348-A1 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE | UNIVERSITY OF SOUTH FLORIDA | 2023-09-14 | — | — | US | claimed |
| US-20200397736-A1 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE | UNIVERSITY OF SOUTH FLORIDA | 2020-12-24 | — | — | US | claimed |
| EP-3723511-A1 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE | University of South Florida (US) | 2020-10-21 | — | — | EP | claimed |
| WO-2019118624-A1 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE | UNIVERSITY OF SOUTH FLORIDA (US) | 2019-06-20 | — | — | WO | claimed |
| CN-108042516-A | Application of R, S-1,3- the butanediol acetoacetate diester in prevention or treatment decompression medicine is prepared | 中国人民解放军第二军医大学 | 2018-05-18 | — | — | CN | claimed |
| US-20170266147-A1 | METHODS OF INCREASING LATENCY OF ANESTHETIC INDUCTION USING KETONE SUPPLEMENTATION | NAVY, SECRETARY OF THE UNITED STATES OF AMERICA | 2017-09-21 | — | — | US | claimed |
| US-11974973-B2 | Ketone supplements-evoked effect on absence epilepsy by co-administration of uridine | UNIVERSITY OF SOUTH FLORIDA (US) | 2024-05-07 | — | — | US | disclosed |
| EP-3788109-B1 | METHOD FOR PROVIDING SUBSTRATE COATED WITH A CURED DAMPING COATING AND COATED SUBSTRATE SO PROVIDED | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-07 | — | — | EP | disclosed |
| US-11643569-B2 | Method for providing substrate coated with a cured damping coating and coated substrate so provided | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-05-09 | — | — | US | disclosed |
| CN-112004894-B | Method for providing a substrate coated with a cured damping coating and the provided coated substrate | 陶氏环球技术有限责任公司 | 2022-09-27 | — | — | CN | disclosed |
| US-20220218635-A1 | KETONE SUPPLEMENTS-EVOKED EFFECT ON ABSENCE EPILEPSY BY CO-ADMINISTRATION OF URIDINE | EOTVOS LORAND UNIVERSITY (HU) | 2022-07-14 | — | — | US | disclosed |
| US-20210338613-A1 | FORMULATIONS AND METHODS FOR TRANSDERMAL ADMINISTRATION OF KETONES | DYVE BIOSCIENCES, INC. (US) | 2021-11-04 | — | — | US | disclosed |
| US-20210290581-A1 | NEUROREGENERATION IMPROVED BY KETONE | UNIVERSITY OF SOUTH FLORIDA | 2021-09-23 | — | — | US | disclosed |
| WO-2015156865-A1 | METHODS OF SUSTAINING DIETARY KETOSIS AND ITS EFFECTS ON LIPID PROFILE | UNIVERSITY OF SOUTH FLORIDA (US) | 2015-10-15 | — | — | WO | disclosed |
| US-20140072654-A1 | CANCER WITH METABOLIC THERAPY AND HYPERBARIC OXYGEN | SAVIND, INC. (US) | 2014-03-13 | — | — | US | disclosed |
| US-20140073693-A1 | USE OF KETONE ESTERS FOR PREVENTION OF CNS OXYGEN TOXICITY | SAVIND, INC. (US) | 2014-03-13 | — | — | US | disclosed |
| WO-2012154837-A2 | THE USE OF KETONE ESTERS FOR PREVENTION OF CNS OXYGEN TOXICITY | UNIVERSITY OF SOUTH FLORIDA (US) | 2012-11-15 | — | — | WO | disclosed |
| US-5126373-A | Ester or diester of 1,3-butanediol or 1,3-pentanediol; side effect reduction | BRUNENGRABER HENRI (US) | 1992-06-30 | — | — | US | disclosed |
| US-4997976-A | Use of 1,3-butanediol acetoacetate in parenteral oral nutrition | BRUNENGRABER HENRI (CA) | 1991-03-05 | — | — | US | disclosed |
| EP-0318357-A2 | 1,3-Butanediol acetoacetate and its use in parenteral and oral nutrition | Brunengraber, Henri (CA) | 1989-05-31 | — | — | EP | disclosed |